Compare ARK Genomic Revolution ETF (ARKG) vs Roundhill S&P 500 0DTE Covered Call Strategy ETF (XDTE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Roundhill S&P 500 0DTE Covered Call Strategy ETF — how do they compare? ARK Genomic Revolution ETF trades at $44.62, while Roundhill S&P 500 0DTE Covered Call Strategy ETF trades at $39.49. The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Roundhill S&P 500 0DTE Covered Call Strategy ETF nearer its low. Which is the better fit depends on your goals.
| ARKG | XDTE | |
|---|---|---|
Sector | Sector/Thematic | Income / Options Overlay |
52-Week High | $44.55 | $44.76 |
52-Week Low | $24.02 | $36.00 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $44.49, up 0.41% today, with a bullish technical bias from moving averages but overbought RSI signals. The ETF focuses on genomic revolution stocks, with top 10 holdings comprising 59% of assets and a long-term EPS growth rate of 10.7% (Seeking Alpha, 2026-07-28). Recent news highlights biotech sector strength driven by FDA friendliness and AI-driven drug discovery.
Outlook is cautiously optimistic given sector tailwinds, but high concentration and volatility pose risks. The ETF's exposure to small- and mid-cap biotech offers growth potential, yet investors face regulatory and market sentiment shifts. Near-term performance may hinge on broader tech trends and biotech M&A activity.
XDTE trades at $39.48, up 0.03% with a bullish technical signal from moving averages, though RSI indicates potential overbought conditions. The ETF focuses on weekly income via covered calls on the S&P 500, with recent dividends averaging around $0.15 per week. Financial ratios are not disclosed, and news highlights high yield claims but questions sustainability.
Outlook hinges on income strategy appeal amid market stability; opportunities include consistent payouts, but risks involve NAV erosion and fee drag. Investor caution is warranted due to mixed sentiment and reliance on options premiums.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Roundhill S&P 500 0DTE Covered Call Strategy ETF
XDTE is an actively managed ETF that utilizes a synthetic covered call strategy on the S&P 500 Index using zero-days-to-expiration (0DTE) options. It seeks to provide high weekly income and overnight exposure to the index while mitigating some volatility through daily option premium harvesting.
Read more on XDTE →
